Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Professor Sir Roy Calne
2 new employees. David Crockford & Roy Caine
REORGANIZATION!!!
Expect 8k's any day now.
It could be just days away. This won't stay in trips for long.
There's no need. They're not gonna disclose anything with emails.
Yup!!! Filings are coming for sure.
Notice the dates updated.
https://www.zoominfo.com/pic/regen-biopharma-inc/357573368
Entity Status: Active
https://esos.nv.gov/EntitySearch/BusinessInformation
Congrats longs who stuck it out.
Just found something HUGE!!!!
Its gonna be crazy here this coming weeks.
The Company is focused on the IMMUNOLOGY and IMMUNOTHERAPY space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
And I thought you were a bad dude. lol.
You know whats going on. Thanks for getting my 6s filled.
REORGANIZATION!!!
Good buy. The volume the last 4 trading days is very telling this will continue to climb.
$5.3 MILLION!!! today. Follow the money!!
Going pennies!!
BIG SMACKS!!
Who knows. But I appreciated. Got my 6s.
Will hold for a while.
Thank you. $$$
Keep loading this 6s and 7s
That's for sure. Its thinning out.
Yes. Exactly!
CFGN is bidding. Trying to cover short positions. Don't give em any.
Accumulation bigtime. Anybody want fill me some 6s??
https://www.stockscores.com/charts/charts/?ticker=Rgbp+
I think a merger is in the works. Imo
415,571,349!!! Volume. $254k worth
A lot of interest here. Why???
Are this the reason's why this is being accumulated. A few articles mentioned Regen Biopharma Inc's name.
https://news.google.com/search?cf=all&hl=en-US&pz=1&q=Regen+BioPharma&gl=US&ceid=US:en
So was this patent approved???
Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation
Published: Aug 07, 2019
SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in an efficacious manner while appearing not to induce any form of toxicity.
In a series of experiments, Regen collaborators extracted immune system cells from mice called 'dendritic cells'. These cells where treated with cannabidiol, which caused suppression of their ability to activate cancer killing immune T cells. Surprisingly, in the
presence of NR2F6 inhibition, the cannabidiol actually increased ability to activate T cells. The Company currently possesses small molecule inhibitors of NR2F6, as well as various genetic means such as inducers of RNA Interference, to block expression of NR2F6.
"Numerous studies have shown the NR2F6 is critically involved in the ability of cancer cells to resist death, as well as to possess other pathogenic properties (1-3)," according to Thomas Ichim, PhD, co-inventor of the patent and a senior scientific consultant to Regen BioPharma Inc. "It is very interesting that NR2F6 also acts as an 'immunological checkpoint' in that it prevents immune system activation (4-6). By using small molecules, as well as RNA interference, we are able to de-repress the immune system in cancer models. What is striking about the data disclosed today is that inhibition of NR2F6 not only increases activity of dendritic cells, but also changes cannabidiol from an immune inhibitor to an immune stimulator."
Chairman and CEO David Koos noted, "Checkpoint inhibitors are a new class of drugs, which include Ipilimumab (Yervoy® Bristol Myers Squibb, 2018 estimated sales of $1.5 Billion1), and Pembrolizumab (Keytruda® Merck, 2017 sales of $3.4 Billion2). Current checkpoint inhibitors act to augment immune responses but do not have direct anticancer effects. By creating approaches to inhibit NR2F6, the Company aims to develop a new class of checkpoint inhibitors that concurrently block tumor growth while enhancing the immune system."
About Regen BioPharma Inc.:
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
August is prime time for anti coronavirus equipment for schools. Expecting some pr's in the coming days.
Over half a MILLION in dollar volume today.
That's a lot of dough. Follow the money
Clean trading today. No t trades.